At Manningham Medical Centre, you can find all the data about Clearside Biomedical Atlanta. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Clearside Biomedical

    https://clearsidebio.com/
    Clearside Biomedical clearsidebio 2022-05-22T00:09:17+00:00. LEARN ABOUT SUPRACHOROIDAL ADMINISTRATION. FIRST & ONLY FDA APPROVED PRODUCT …

Clearside Biomedical, Inc. | LinkedIn

    https://www.linkedin.com/company/clearside-biomedical-inc-
    Clearside Biomedical, Inc. Biotechnology Research Alpharetta, GA 1,737 followers Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®)

Clearside Biomedical Announces Leadership Team Update

    https://www.globenewswire.com/en/news-release/2023/02/06/2601955/0/en/Clearside-Biomedical-Announces-Leadership-Team-Update.html
    ALPHARETTA, Ga., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the …

Clearside Biomedical OASIS Data to be Presented at …

    https://www.globenewswire.com/en/news-release/2023/02/07/2602829/0/en/Clearside-Biomedical-OASIS-Data-to-be-Presented-at-Multiple-Upcoming-Medical-Meetings-in-February-2023.html
    ALPHARETTA, Ga, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the …

Startup receives $7.9 million in venture capital, pharma …

    https://news.emory.edu/stories/2013/03/clearside_7_9_million_funding/
    John Toon. (404) 894-6986. [email protected]. Clearside Biomedical, Inc. an Atlanta-based ophthalmic pharmaceutical company launched from …

Clearside Biomedical Announces Positive 6-Month Results

    https://www.globenewswire.com/en/news-release/2023/02/02/2600340/0/en/Clearside-Biomedical-Announces-Positive-6-Month-Results-from-OASIS-Extension-Study-with-Suprachoroidal-CLS-AX-axitinib-injectable-suspension-in-Wet-AMD.html
    Durability in the 6-Month Extension Study in Cohorts 3 & 4 at higher doses (n=12) 77% - 85% reduction in treatment burden was observed compared to the average …

Clearside Biomedical Inc. hires interim CEO George …

    https://www.bizjournals.com/atlanta/news/2020/03/17/eye-disease-pharmaceutical-company-makes-change-at.html
    There's a new face at the head of one of metro Atlanta's biopharmaceutical companies. Alpharetta-based Clearside Biomedical Inc. (NASDAQ: CLSD) announced …



Need more information about Clearside Biomedical Atlanta?

At Manningham Medical Centre, we collected data on more than just Clearside Biomedical Atlanta. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.